drugset / Trial / NCT04110418
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized, prospective study comparing methylene blue versus terlipressin in treatment of catecholamines resistant shock in preterm neonate
Timeline
- Start
- 2019-02-19
- Primary completion
- 2020-02-19
- Completion
- 2020-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylene Blue | Diagnostic / imaging agent | 0.15 mg/kg | Intravenous |
| Comparator | Terlipressin | Peptide | 20 ug/kg | Intravenous |